Synthesis and structure-activity relationships of novel antiseptics

https://doi.org/10.1016/S0960-894X(97)00297-7Get rights and content

Abstract

For the purpose of developing new antiseptics, we searched for compounds having high biocidal activity covering both gram-positive and gram-negative bacteria. Accordingly, we designed 1,5-disubstituted biguanides and synthesized them using two alternative efficient reaction schemes. The bactericidal activity of these biguanides was assayed by the micro titration plate method. Among the biguanides synthesized, 3,4-dichlorobenzyl derivatives were found to exhibit particularly high bactericidal activity. Ultimately, compound 11 was chosen as a candidate novel antiseptic, which is currently under continued evaluation.

For the purpose of developing new antiseptics, we searched for compounds having high biocidal activity covering both gram-positive and gram-negative bacteria. Accordingly, we designed 1,5-disubstituted biguanides and synthesized them using two alternative efficient reaction schemes. The bactericidal activity of these biguanides was assayed by the micro titration plate method. Among the biguanides synthesized, 3,4-dichlorobenzyl derivatives were found to exhibit particularly high bactericidal activity. Ultimately, compound 11 was chosen as a candidate novel antiseptic, which is currently under continued evaluation.

  1. Download : Download full-size image

References (18)

  • A.D. Russell et al.

    Int. J. Pharm.

    (1987)
  • I.S.I. Al-Adham et al.

    Int. J. Pharm.

    (1986)
  • B.D. Cookson et al.

    Lancet

    (1991)
  • T.E. Gunda et al.

    Eur. J. Med. Chem.

    (1991)
  • K. Jôno et al.

    Chem. Pharm. Bull.

    (1986)
  • I.A. Schmitz et al.

    Manufacturing Chemist.

    (1958)
  • K. Jôno et al.

    Yakugaku Zasshi

    (1985)
  • A.D. Russell

    Infection (München)

    (1986)
  • J.T. Shaw et al.

    J. Org. Chem.

    (1959)
There are more references available in the full text version of this article.

Cited by (26)

  • Biguanides: Species with versatile therapeutic applications

    2021, European Journal of Medicinal Chemistry
    Citation Excerpt :

    The antimicrobial activity of polymeric chlorhexidine release device was assessed in dentinal tubule infection using in vitro model of E. faecalis. The study suggested that this novel polymeric chlorhexidine-controlled release device can be effective medication against E. faecalis [463]. In 2012, Kim et al. compared the antimicrobial effectiveness of alexidine (1%) and chlorhexidine (2%) on dentin blocks infected by E. faecalis.

  • Olanexidine gluconate versus povidone-iodine for preventing surgical-site infection in orthopaedic surgery: A retrospective study

    2019, Journal of Orthopaedic Science
    Citation Excerpt :

    Antiseptic solutions more effective than chlorhexidine and PVP-I for the SSI reduction are expected to be developed in the future years for orthopaedic surgeries. Olanexidine gluconate [1-(3,4-dichlorobenzyl)-5-octylbibuanide gluconate] (OLG) (Otsuka Pharmaceutical Factory, Tokushima, Japan) is a newly developed biguanide-based antiseptic for preoperative skin preparation, launched in Japan in 1997 [12], and has been available in clinical settings since 2015. OLG is a broader spectrum antiseptic compared to chlorhexidine or PVP-I [13,14].

View all citing articles on Scopus
View full text